Anika Therapeutics, Inc.
Anika Therapeutics Receives FDA Approval for ELEVESS Product
Published in Lab Business Week, August 12th, 2007
Anika Therapeutics, Inc. (Nasdaq: ANIK) announced that it has received U.S. FDA approval for commercial sale of its corrective and aesthetic dermatology product. This product is licensed to Galderma Pharma, S.A. who will launch it worldwide under its proprietary brand name, ELEVESS(TM). ELEVESS is an injectable soft tissue filler for facial wrinkles and scar remediation. The product is based on Anika's chemically modified hyaluronic acid (HA) proprietary technology and incorporates lidocaine, a local anesthetic. ELEVESS offers the highest concentration of cross-linked HA available in a dermal filler, which results in a long duration of effect. Anika previously announced on April 12, 2007...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
Source: Lab Business Week (2007-08-12)
More Articles from Lab Business Week
- Auriga Laboratories, Inc.
Auriga Laboratories Appoints Lisa Tripodi as Vice President of Trade Relations - Autism
New Model for Autism Suggests Women Carry the Disorder and Explains Age as a Risk Factor - Biochips
Biochips can save lives in Myocardial Infarction patients - Biomedical Engineering
Researchers at Abbott Laboratories target biomedical engineering - Cancer Vaccines
Milford Medical Laboratory Offers No-False-Positive DNA-sequencing Human Papillomavirus (HPV), Chlamydia and Gonococcus Tests - Clinical and Laboratory Standards Institute (CLSI)
CLSI Publishes Guideline on Platelet Function Testing by Aggregometry - More from this issue of Lab Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
